An AI-enabled Bias-Free Respiratory Disease Diagnosis Model using Cough Audio: A Case Study for COVID-19

TL;DR

This paper introduces RBFNet, an AI model that reduces bias from confounding variables in cough-based respiratory disease diagnosis, improving accuracy and reliability especially in biased datasets.

Contribution

The study presents RBFNet, a novel bias mitigation framework using a cGAN architecture for unbiased respiratory disease diagnosis from cough audio.

Findings

RBFNet achieves over 80% accuracy across different confounders.

It outperforms traditional CNN-LSTM models by 5-8% in accuracy.

Demonstrates robustness in highly biased training scenarios.

Abstract

Cough-based diagnosis for Respiratory Diseases (RDs) using Artificial Intelligence (AI) has attracted considerable attention, yet many existing studies overlook confounding variables in their predictive models. These variables can distort the relationship between cough recordings (input data) and RD status (output variable), leading to biased associations and unrealistic model performance. To address this gap, we propose the Bias Free Network (RBFNet), an end to end solution that effectively mitigates the impact of confounders in the training data distribution. RBFNet ensures accurate and unbiased RD diagnosis features, emphasizing its relevance by incorporating a COVID19 dataset in this study. This approach aims to enhance the reliability of AI based RD diagnosis models by navigating the challenges posed by confounding variables. A hybrid of a Convolutional Neural Networks (CNN) and Long-Short Term Memory (LSTM) networks is proposed for the feature encoder module of RBFNet. An additional bias predictor is incorporated in the classification scheme to formulate a conditional Generative Adversarial Network (cGAN) which helps in decorrelating the impact of confounding variables from RD prediction. The merit of RBFNet is demonstrated by comparing classification performance with State of The Art (SoTA) Deep Learning (DL) model (CNN LSTM) after training on different unbalanced COVID-19 data sets, created by using a large scale proprietary cough data set. RBF-Net proved its robustness against extremely biased training scenarios by achieving test set accuracies of 84.1%, 84.6%, and 80.5% for the following confounding variables gender, age, and smoking status, respectively. RBF-Net outperforms the CNN-LSTM model test set accuracies by 5.5%, 7.7%, and 8.2%, respectively